For patients with obesity initiating pharmacotherapy with semaglutide or tirzepatide, weight loss at one year is 8.7 percent ...

Diabetic weight-loss medications are effective for people with schizophrenia without affecting psychotic symptoms, University ...

Diabetic weight loss medications are effective for people with schizophrenia without affecting psychotic symptoms, University ...

The following is a summary of “Oral semaglutide for the treatment of obesity: a retrospective real-world study,” published in ...

Variants of obesity-related genes influence how much weight patients lose on specific weight loss drugs like liraglutide, two studies report.

Experts say that semaglutide and tirzepatide can help patients with heart failure lose weight, but limited NHS access is ...

Researchers have identified the brain cells responsible for the weight-loss effects of semaglutide without triggering its undesirable side effects. This discovery paves the way for more targeted ...

A recent study done in the U.S. showed that semaglutide and tirzepatide — injectable GLP-1 drugs for obesity — produce lower weight loss in a real-world setting, than during the clinical trial ...

Weight-loss drugs that mimic the effect of regulatory hormones on appetite and energy balance often come with a few rather ...

At the least, the new 7.2mg results point to scope for hiking the semaglutide dose in CagriSema to chase down that weight-loss target. The company is also running a phase 3b trial of 7.2mg ...

There's no magic bullet yet -- but for people with obesity, weight loss drugs can be a helpful ... enough leptin is a sign that you've eaten as much as you need, and your brain triggers feelings ...

As the popularity of GLP-1 medications to support weight loss in adults surges, it’s not surprising that there’s also been a spike in the use of these drugs in teens. Prescriptions of the GLP ...